Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 289
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
Entheon Biomedical Announces Nancy Maher, Special Advisor of Data Science and...
Bright Minds Biosciences (“BMB”) Proprietary 5-HT2C Agonists Show Significant Reduction in...
BetterLife Engages Eurofins CDMO for Next Generation Psychedelic TD-0148A Manufacturing
MINDCURE Announces Manufacturing of Synthetic Ibogaine to be Used in Company’s...
Nova Mentis Launches Autism Microbiome Study in the United States
Awakn Announces Exclusive License Deal with the University of Exeter to...
Can Psilocybin and LSD Relieve Existential Suffering?
Experiential Psilocybin-assisted Therapy Training Program, Approved by Health Canada, Gets Underway
OPTIMI HEALTH and NUMINUS WELLNESS to Conduct Psychedelic Lab Research and...
Red Light Holland Launches New Logo and Interactive Wisdom Truffle Companion...
Load more